Around 2,150 jobs at risk as Claire's Accessories appoints administrators
Claire's UK stores will remain open as usual once administrators are brought in, and store staff will stay in their positions while the options for the retailer are assessed, the company announced.
Claire's runs 2,750 stores across the world, including 15 stores in Ireland.
Chris Cramer, chief executive of the fashion and accessories chain, said: 'This decision, while difficult, is part of our broader effort to protect the long-term value of Claire's across all markets.
'In the UK, taking this step will allow us to continue to trade the business while we explore the best possible path forward.
Advertisement
'We are deeply grateful to our employees, partners and our customers during this challenging period.'
The US-based business filed for bankruptcy in a court in Delaware last week.
It is the second time the group has declared bankruptcy, after first filing for the process in 2018 after it was unable to repay a loan.
The group saw its finances improve after wiping around $1.9 billion (€1.6 billion) off its balance sheet in a refinancing but has come under pressure from recent weak consumer demand and supply chain uncertainty.
Initially its UK stores were to be unaffected by the bankruptcy process, but the latest news indicates the opposite.
Last month, Sky News reported that Claire's is working with advisers from Interpath to seek a potential sale or restructuring of its UK business.
The US group said it is continuing in strategic review for the business, including discussions with 'potential strategic partners'.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
3 hours ago
- Irish Times
From pharma to food, the known unknowns of Trump's EU tariffs deal
The US/ EU tariff deal was meant to bring certainty for exporters. But almost three weeks later there is a lot that we don't know – and more that remains uncertain. A joint statement signed off by both sides had been expected shortly after the big summit in Scotland at the end of July , clarifying key parts of the deal and how it would be implemented. But this week, a European Commission spokesperson said, in best bureacrateese, that while further contacts with the US were expected on this, 'I don't believe at this stage we can put a timeline on these engagements.' 1. What is covered by the new tariffs? The deal had been hailed as bringing 'certainty' to Irish exporters. And it has done so, but only up to a point. A blanket 15 per cent tariff now applies on most categories or exports from Ireland to the US. READ MORE As ever with trade, there are tweaks. Some goods which had been subject to previous higher tariff charges (under the most favoured nation or MFN system) will still pay these. For Ireland, the main product affected here is butter – with Kerrygold now the second biggest seller on the US market. Before Trump came to office it had been levied at a rate based on weight – rather than the more usual percentage calculation. However, this worked out at somewhere over 16 per cent in practice. So this slightly higher rate will remain. Other sectors face tariffs for the first time, or higher charges. For example, the large medical products sector had previously been largely exempted, but is now being levied at 15 per cent. So are parts of the food sector and spirits. 2. What is not covered? US customs has published a list of goods that are excluded from the 15 per cent tariff and Carol Lynch, customs partner at BDO, says this is a good place for SMEs unsure if they are covered to check. A key point for Ireland is that pharma products, by far the State's biggest in value terms, are not currently subject to the 15 per cent tariff. This may change, as the Trump administration is undertaking a study of pharma supply into the US market and the national security issues that apply – the so-called section 232 investigation which refers back to a 1960s act of congress. This is the backdrop to Trump's talk of 150 per cent or 250 per cent tariffs on pharma in 18 months or two years' time, applying to companies that do not play ball and return production to the US market. The EU believes the US has signed up to a 15 per cent cap on pharma – and semiconductor – tariffs under the deal, but Trump's subsequent statements suggest otherwise. This is why the absence of a joint agreed statement between the EU and US is important. 3. What might change? Another frustration for the EU is that the outline agreement suggested that more areas would be excluded from the 15 per cent tariff net but, beyond aircraft and aircraft parts, none of these has yet been spelt out. These 'carveouts' were due to cover some areas of food of potential interest to Ireland, some generic drugs and chemicals and perhaps medical devices, a sector which typically has lower margins and fixed price contracts with US buyers. The EU had also been pushing for a 'zero for zero' tariff deal on wines and spirits, though the indications were the US was unlikely to concede this. So bar the list published by US Customs, we are no wiser on what other sectors may, in time, get a pass. 4. What can companies do? The practical steps, according to Lynch of BDO, are, first, to check whether goods were in transit before August 7th, in which case the old 10 per cent rate would apply rather than the new 15 per cent. Companies need to know the tariff codes being used by those importing their products and whether any of the exclusions they know about so far apply. And, she says, they need to examine whether they have any flexibility under the rules in terms of the value of goods declared for customs purposes. This is a complex area with detailed pricing rules applying but, particularly in high value sectors like pharma, companies may have options to readjust supply changes or pricing policies to cut their tariff bills. 5. Where next on pharma? The Trump administration has been promising the results of its section 232 investigation shortly, expected by way of a big report. Alongside this, Trump's team have been negotiating on prices with the big US pharma companies, demanding that they charge the same prices in the US as other countries. A 2022 study showed that US prices were, on average, three times higher than the OECD average. This – in Trump's view- means prices should fall in the US and rise in other countries, thus giving the US consumer a better deal while giving companies ongoing revenue to fund research. It is unclear what the outcome of this will be but the two areas are linked. Imposing tariffs on imports risks increasing prices on the US market, the opposite of the goal of the price negotiations. The US president is threatening tariffs which would gradually increase over time as a way of getting big pharma to relocate more production to the US of key drugs and ingredients. So will we see 15 per cent pharma tariffs when the result of the Section 232 probes are out? Or will the US president hold off for now while holding out the threat of tariffs if big pharma does not fall into line on prices and investment? 6. Ireland's pharma exposure: In a post on the pharma issue on LinkedIn, Ben McConkey, an Irish MSc student at the London School of Economics, underlines the extent of Ireland's 'pharma' exposure by pointing out that the US imported over $50 billion worth of Irish pharmaceutical products in 2004, making it the single largest category of goods imported from any EU country by a margin of $15 billion and representing 8.3 per cent of all US imports from the EU. While the noise around the trade talks was about German cars, Irish pharma exports have a higher value, though this is of course hugely inflated by the pricing practices of the firms involved, which have a financial incentive to declare as much profit as possible in low tax Ireland. McConkey also makes the interesting point that the bulk of Irish pharma and organic chemicals go to republican states such as Indiana – home of Eli Lilly – as well as Puerto Rico, North Carolina and Illinois. Many are not finished drugs but are high value ingredients in drugs then sold across the US. As tariffs will have an economic impact on these companies – and on US consumers – it remains to be seen what the president decides. But the stakes for Ireland in the Section 232 process are huge as it could influence both future manufacturing investment and the transfer pricing structures the companies employ which led to huge profits being declared in Ireland and a lot of corporate tax being paid here. 7. The uncertainty may just roll on: The EU's belief was that a joint statement would be agreed with the US on the basis of the political agreement between Trump and European Commission president Ursula von der Leyen in Scotland. This would then be followed by further detailed negotiations. It is unclear if the absence of even a basic, joint written understanding is just a result of August holidays or whether it is a sign of the way the US president tends to operate – in headlines and in a way which leaves him with maximum flexibility to change tack. The president and his team have been continuing to push the boat out in terms of tariffs and pressure on US businesses to bend to their will. There is a fair chance that the uncertainty will roll on – and on. And this in itself will have a cost on businesses, even if the 15 per cent deal will have left many feeling they have some more solid ground on which to plan. And, it must be remembered that the US president's right to impose the 15 per cent tariffs at all is being challenged in the courts – a process likely to go right to the US supreme court for an ultimate decision.
Irish Examiner
9 hours ago
- Irish Examiner
Cork's two towers: PJ Hegarty to reprise Elysian 20 years on at taller 85m high Railyard tower
WORK on Ireland's tallest tower, for an 85 metre high apartment tower, on the former Sextant pub/Carey tool site, is slated to start next month, with a two-year delivery timeline to September 2027 facing contractors, PJ Hegarty – the same firm that built the adjacent Elysian tower which competed in 2008. Due on site now after an almost two decade hiatus in Cork's 'towering ambitions' is Railyard apartments, a cost rental led/social housing scheme of 217 homes in a 24 storey tower, in a joint development between JCD Group and Cork City Council on Albert Street/Albert Quay, just 200 metres downriver of City Hall. Lead contractor on the 85m tall Railyard is Cork-based PJ Hegarty, who delivered the then-tallest Irish building The Elysian at 71m/233' (or 79m high inc the antenna) over a double basement in 2007/2008, on a site acquired by O'Flynn Group from An Post. Hegarty's also did significant office schemes at Cork's Penrose Dock and 85 South Mall for Railyard developers JCD Group and they did the city's first significant docklands development, City Quarter, also over a double basement, for Howard Holdings in the mid-2000s. Currently, Ireland's tallest tower is the Obel building in Belfast at 85 metres, with 233 apartment plus offices. Dublin's tallest apartment building in the mixed use Capital Dock, with 190 units in a c €280m 690,000 sq ft scheme done by Kennedy Wilson/Nama. Capital Dock by O'Mahony Pike. Cork's Railyard scheme will drop from a 24 storey tower to 11 and nine floors with public realm, and will integrate part of the former Blackrock and Passage rail line terminus/heritage buildings: the former Sextant bar was demolished in August 2020. Lost bearings: the Sextant bar site is about to reach new heights Sign of the times: Jonny O'Mahony and Michael Droney putting up the Sextant boat sign on the wall of their bar at Albert Quay in 2009. Plans for the site initially were for a 201 unit Buy to Rent scheme in a 25 story tower; when this proved financially unviable, plans were amended for offices, and later a partnership deal with Cork City Hall for cost-rental-led homes ensure the start plans for next month after a Part 8 approval with the Council in October 2024. Railyard Apartments was designed by award winning architects Henry J Lyons, in collaboration with tall building specialist architect Richard Coleman of City Designer. Henry J Lyons also designed Dublin's College Square (currently under construction), a 82 metre 22 story tower with 11 floors of offices and 11 of apartments, near Trinity College and Tara Street. Meanwhile, the planning clock is ticking down on the plans for a 34 storey/140 metres hotel tower on the Port of Cork site for US-based developer Tower Group, with planning cleared by An Bord Pleanala in October 2021. Site drilling at the Custom House/Port of Cork in 2017 where a hotel and high rise tower was approved by An Bord Pleanala. Close-by, c 300 apartments are under advanced construction at Horgans Quay after the Land Development Agency (LDA) got involved with private developers Clarendon/BAM in a mixed use scheme, with tenure aimed at cost-rental (c200) plus up to 100 private purchasers under Croí Cónaithe assistance.
Agriland
9 hours ago
- Agriland
Nenagh farmer named Arrabawn Tipperary Co-op 'Milk Supplier of the Year'
Dairy processor, Arrabawn Tipperary Co-op has announced the winner of its 2024 Milk Supplier of the Year award. The Tipperary dairy farmer, Ned Kelly was named the winner of the award yesterday (Tuesday, August 12). A spokesperson for the dairy processor said: "With an impressive combination of sustainability, milk quality, animal care, and family dedication, the Kelly farm stands as a shining example of the best of Irish dairy farming. "Arrabawn Tipperary Co-op would like to congratulate Ned Kelly and his family on winning the very prestigious award." The co-op also expressed its thanks to the Kelly family for representing Arrabawn Tipperary Co-Op to the "highest of standards" in their role as a milk supplier. Kelly is the first winner of the award since the merger of Arrabawn Co-operative Society and Tipperary Co-operative Creameries back in February 2025. Kelly, who is based just outside Nenagh in Ballycommon is milking 141 cows along the banks of Lough Derg. The north Tipperary family farm has being run by the Kellys since 1973 experiencing much growth over the years such as the 2023 upgrade to a 12-unit double-up parlour to improve labour efficiency. On February 28, 2025, Arrabawn Tipperary Co-operative Society was formally established following a merger of Arrabawn Co-operative Society and Tipperary Co-operative Creameries. The decision to merge the two companies into the current dairy and agri-trading cooperative came in November 2024. The new co-op owned by over 4,800 members, has 1,400 dairy farmer suppliers spanning across 16 counties and supplying approximately 750 million litres of milk annually. The merger led to the co-op owning: Two primary ingredient manufacturing facilities at Nenagh and Tipperary town, processing almost 900 million litres of milk products annually; 15 agri-trading stores, including facilities at Nenagh, Tipperary town and Athenry; Feed brand Dan O'Connor Feeds; French-based cheese production facility Tippagral. In May, the co-op appointed Co. Cork native, Eamon O'Sullivan as its first CEO since the merger.
